# Task Report

task_id: RHL-M3B-3B-FIX-059-MODULE-INPUT-TELEMETRY
status: READY_FOR_SOL_REVIEW
baseline: f2b3b511e747223e3a16e5196adf175f73e3e557
branch: codex/m3b-3b-evidence-routing
implementation_commit: 460d9f617e6fd222a6be9dab32538877e138c85c
verified_remote_tip: 460d9f617e6fd222a6be9dab32538877e138c85c
sync_status: SYNCED
summary: Add privacy-safe module input telemetry to TEST-054 so accepted provider evidence can be distinguished from evidence that was never routed to a module.
tests: Focused TEST-054 harness tests 9/9 passed; repository typecheck and diff check passed; latest real TEST-054 completed the full Workflow/Gateway/ChangeSet/Writer path and proved CPCA evidence was routed to risk_analysis.
acceptance_criteria: Each industry module analysis call records only its module identity and bounded evidence IDs; no source bodies, prompts, or model responses are persisted; the existing product-quality gate and seven-provider portfolio remain unchanged.
governance_status: Active governance manifest and applicable governance documents were read. The change is limited to TEST-054 validation telemetry and its evidence artifact; no governance or architecture file was changed.
blockers: Product-quality acceptance remains blocked by insufficient evidence coverage. The telemetry confirms CPCA routing is functioning for the observed risk evidence; no adapter change is justified by this run.
task_input_quality: complete
missing_information_resolved_by_luna: none

## Changes

- Extended the TEST-054 reasoning wrapper to record module input evidence IDs for each `industry_module_analysis` call.
- Kept telemetry bounded to operation, module, and evidence identifiers; no content or model output was added.
- Refreshed the sanitized TEST-054 evidence artifact with the new module-input trace.

## Validation Results

- command: `npx tsx --test tests/validation/industry-seven-provider-product-quality-after-docling-ready.test.ts`
  result: 9 tests passed.
- command: `npm run typecheck`
  result: Passed.
- command: `git diff --check`
  result: Passed; only line-ending normalization warnings were emitted.
- command: `node --import tsx tests/validation/industry-seven-provider-product-quality-after-docling-ready.ts`
  result: Real run completed with parser preflight `READY`, Workflow `completed`, two acquisition waves, eight module calls, one Gateway, one ChangeSet, one Writer, Canonical validation passed, 16-section report generated, and final classification `INDUSTRY_PRODUCT_QUALITY_BLOCKED_BY_EVIDENCE`.

## Important Design Decisions

- Record evidence IDs at the reasoning boundary because this is the smallest point that exposes actual module routing without persisting source text.
- Preserve all existing provider and Workflow semantics; this is diagnostic instrumentation only.
- Use the trace to distinguish absent routed evidence from model-side rejection or unavailable module coverage.

## Debugging Summary

- The latest trace shows MIIT evidence IDs entering `industry_definition` and the CPCA evidence ID entering `risk_analysis`.
- The other six module calls received empty evidence arrays in this run, which is consistent with the remaining product-quality gaps.
- CPCA therefore does not have a deterministic routing defect in this observed run; its remaining limitation is evidence strength/coverage, not a missing module binding.

## Remaining Risks

- Provider outcomes remain variable: GDELT, Eastmoney, and AKShare may fail or return no qualifying evidence.
- Model-generated module gap sets vary across live runs; the persisted trace is necessary for each run-specific diagnosis.

## Scope Deviations

- none

## Sol Review Notes

- Use the module-input trace in subsequent source-coverage work; do not alter CPCA routing or relax the product-quality gate without new source-backed evidence.
